Skip to content
Back to Guavy Wire
Stocks

Psychedelic Therapy Gains Attention as Possible Treatment for Depression

Instruments
AMZN
Share

Claire Torpey, from Tynemouth in North Tyneside, had tried traditional mental health support before attending psychedelic retreats in Central and South America. She says she was still struggling with depression after trying counselling.

She attended retreats where participants legally take psychedelics as part of guided therapeutic programmes. The retreats involved psilocybin, the psychoactive compound found in magic mushrooms, and ayahuasca, a traditional Amazonian brew containing the psychedelic compound DMT.

Claire says the experience was transformative: 'It wasn't until I started taking these medicines that it started to lift. I started to find a place of peace and happiness.' She believes psychedelic therapy helped her address underlying thoughts and emotions.

In the UK, researchers are investigating whether psilocybin could help treat conditions including depression at Newcastle's Care Pathway Enhancement (CaPE) Clinic. Lead researcher Dr Mourad Wahba says participants often report significant shifts in how they view themselves and their experiences after receiving psilocybin in a controlled setting.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc